MarketPeel
Insider Trading Intelligence
Pricing
…
RF

Ramy Farid

VIR
DIRECTOR · VIR BIOTECHNOLOGY, INC. · CIK 0001797707
FILING MIX · LIFETIME57%/43%
BUYS
26
SELLS
20
TOTAL VALUE
$17.07M
COMPANIES
3
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
3,276,495
AVG SELL PX
$39.64
TRADE KIND
SHOWING 46 / 46
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 14 pending
Forward-return performance of every backtestable P/S trade by Ramy Farid, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+50.00%-1.50%-0.46%-1.04%-0.90%—
14d16+75.00%-3.51%+1.25%-4.76%-6.13%—
30d16+68.75%-7.80%+0.14%-7.93%-12.85%—
60d16+62.50%+1.44%+5.06%-3.63%-9.08%—
90d16(2 pending)+57.14%-2.73%+5.95%-12.69%-29.91%—
180d16(4 pending)+8.33%+58.03%+16.31%+41.73%+37.13%—
1y16(4 pending)+75.00%+7.58%+32.15%-24.57%-45.10%—
2y16(4 pending)+91.67%-40.81%+32.25%-73.06%-83.11%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VIR · 16,000 shares · as of May 27, 2026
08,00016,00024,00032,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 26 buys / 20 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
16,000——16,000May 27, 2026May 28, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
8,000——32,000May 27, 2026May 28, 2026 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASE
President & CEO
43,000$3.07$132.0K373,824Apr 17, 2026Apr 17, 2026 ↗View →
SDGR
SCHRODINGER, INC.
SALE10b5-1
10b5-1 plan
43,000$12.21$524.9K330,824Apr 17, 2026Apr 17, 2026 ↗View →
SDGR
SCHRODINGER, INC.
SALE
President & CEO
43,000——74,527Apr 17, 2026Apr 17, 2026 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASE
President & CEO
74,527$3.07$228.8K405,351Apr 17, 2026Apr 17, 2026 ↗View →
SDGR
SCHRODINGER, INC.
SALE
President & CEO
74,527——0Apr 17, 2026Apr 17, 2026 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASE
President & CEO
43,000$3.07$132.0K373,824Apr 16, 2026Apr 17, 2026 ↗View →
SDGR
SCHRODINGER, INC.
SALE
President & CEO
43,000——117,527Apr 16, 2026Apr 17, 2026 ↗View →
SDGR
SCHRODINGER, INC.
SALE10b5-1
10b5-1 plan
43,000$12.33$530.2K330,824Apr 16, 2026Apr 17, 2026 ↗View →
SDGR
SCHRODINGER, INC.
SALE10b5-1
10b5-1 plan
3,661$12.91$47.2K330,824Mar 5, 2026Mar 6, 2026 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
56,250——278,182Mar 2, 2026Mar 3, 2026 ↗View →
SDGR
SCHRODINGER, INC.
SALE10b5-1
10b5-1 plan
5,560$11.90$66.2K334,485Mar 2, 2026Mar 3, 2026 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
13,604——291,786Mar 2, 2026Mar 3, 2026 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
112,500——112,500Mar 2, 2026Mar 3, 2026 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
48,259——340,045Mar 2, 2026Mar 3, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
16,000——16,000May 30, 2025Jun 2, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
8,000——24,000May 30, 2025Jun 2, 2025 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
90,000——90,000Mar 3, 2025Mar 4, 2025 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
60,000——60,000Mar 3, 2025Mar 4, 2025 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
37,500——221,932Mar 3, 2025Mar 4, 2025 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
16,000——16,000May 29, 2024May 31, 2024 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
16,000——16,000May 29, 2024May 31, 2024 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
87,271——87,271Mar 4, 2024Mar 5, 2024 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
126,000——126,000Mar 4, 2024Mar 5, 2024 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
84,960——84,960Feb 9, 2023Feb 10, 2023 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
65,525——65,525Feb 9, 2023Feb 10, 2023 ↗View →
GPCR
STRUCTURE THERAPEUTICS INC.
PURCHASE
275,000$15.00$4.13M275,000Feb 7, 2023Feb 9, 2023 ↗View →
GPCR
STRUCTURE THERAPEUTICS INC.
SALE
642,245——0Feb 7, 2023Feb 9, 2023 ↗View →
GPCR
STRUCTURE THERAPEUTICS INC.
PURCHASE
642,245——3,260,495Feb 7, 2023Feb 9, 2023 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASE
President & CEO
66,886$1.20$80.3K251,318Jan 4, 2023Jan 5, 2023 ↗View →
SDGR
SCHRODINGER, INC.
SALE
President & CEO
66,886——0Jan 4, 2023Jan 5, 2023 ↗View →
SDGR
SCHRODINGER, INC.
SALE
President & CEO
66,886$18.28$1.22M184,432Jan 4, 2023Jan 5, 2023 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
215,000——215,000Feb 9, 2022Feb 9, 2022 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
150,000——150,000Feb 27, 2021Mar 2, 2021 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
10,151$53.61$544.1K184,432Sep 16, 2020Sep 18, 2020 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
9,849$52.81$520.2K194,583Sep 16, 2020Sep 18, 2020 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
15,429$71.49$1.10M204,432Aug 13, 2020Aug 14, 2020 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
18,804$69.83$1.31M235,628Aug 13, 2020Aug 14, 2020 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
15,767$70.62$1.11M219,861Aug 13, 2020Aug 14, 2020 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
4,950$68.54$339.3K254,432Aug 12, 2020Aug 14, 2020 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
34,416$66.92$2.30M295,585Aug 12, 2020Aug 14, 2020 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
1,000$64.87$64.9K333,432Aug 12, 2020Aug 14, 2020 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
36,203$67.72$2.45M259,382Aug 12, 2020Aug 14, 2020 ↗View →
SDGR
SCHRODINGER, INC.
SALE
See Remarks
3,431$66.01$226.5K330,001Aug 12, 2020Aug 14, 2020 ↗View →
SDGR
SCHRODINGER, INC.
PURCHASEGRANT
Stock grant
896,280——896,280Feb 10, 2020Feb 10, 2020 ↗View →
Other insiders · VIR
Loading peer insiders…
About this filer
CIK 0001797707
ROLE
Director
PRIMARY
VIR
COMPANIES
3
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001797707DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback